AHA GUIDELINES Bundle (free trial)

AHA/ASA Early Management of Acute Ischemic Stroke 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1542862

Contents of this Issue

Navigation

Page 29 of 57

30 General Supportive Early Management Table 6. Other Situations Wherein Thrombolysis is Deemed to be Considered Conditions in which benefits of intravenous thrombolysis generally are greater than risks of bleeding Extracranial cervical dissections IV thrombolysis in AIS known or suspected to be associated with extracranial cervical arterial dissection is reasonably safe within 4.5 h and probably recommended. Extra-axial intracranial neoplasms e risk of harm of IV thrombolysis in patients with AIS and extra- axial intracranial neoplam is likely low. Benefit likely outweighs risk in this population and IV thrombolysis should be considered. Angiographic procedural stroke IV thrombolysis in patients with AIS during or immediately post- angiography should be considered as benefit likely outweighs risk in this population. Unruptured intracranial aneurysm The risk of harm of IV thrombolysis in patients with AIS and unruptured intracranial aneurysm is likely low. Benefit likely outweighs risk in this population and treatment with IV thrombolysis should be considered. History of GI/ GU bleeding IV thrombolysis in AIS patients with previous remote history of GI or GU bleeding that is stable may be candidates for IV thrombolysis. Consideration of benefit and risk on an individual basis in conjunction with GI or GU consultation is appropriate. History of MI IV thrombolysis in AIS patients with remote history of MI probably has greater benefit than risk. Recreational drug use IV thrombolysis in AIS patients with known recreational drug use probably has greater benefit than risk in most patients and should be considered. Uncertainty of stroke diagnosis/ stroke mimics When uncertain if a patient is presenting with symptoms due to stroke vs a stroke mimic, unless there are absolute contraindications, the risk of harm with IV thrombolysis is low. The benefit of IV thrombolysis likely outweighs risk in these patients. Moya-Moya IV thrombolysis in AIS patients with Moya-Moya disease does not appear to have an increased risk of ICH and likely provides benefit that outweighs risk.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - AHA/ASA Early Management of Acute Ischemic Stroke 2026